Abstract
|
|
Greystone Research Associates is pleased to announce the publication of a new
market study. Systemic Nasal Sprays: Products, Players, Markets and Forecasts
is a comprehensive evaluation and analysis of the technology, products and
participants providing the driving force behind this evolving segment of the
healthcare sector.
The study is designed to provide drug company decision makers, drug
developers, device packaging designers, healthcare marketers, and supply chain
participants with a detailed understanding of the products, markets and
commercial opportunities for systemic drugs that are administered
intranasally. Provider organization business managers, healthcare
administrators and investors will also benefit from this study.
|
The Evolving Landscape
Drug developers and researchers are discovering that the accessibility and
vascular structure of the nose make it an attractive route for delivering both
small molecule drugs and biologics, systemically as well as across the
blood-brain barrier to the CNS.
Nasal delivery offers the potential for faster onset of action and less
frequent dosing relative to oral drugs. As aging population demographics and
managed care initiatives drive growth in home health care and
self-administration of drug therapies for chronic conditions such as diabetes,
arthritis, and hormone replacement therapy, drug developers are showing
increased interest in routes of administration that are patientfriendly and
cost-effective. Intranasal administration is well positioned to take advantage
of these trends and evolve into a significant role in the future of
pharmaceutical development and commercialization. Intranasal delivery will
grow at the expense of the predominant drug delivery methods (oral and
parenteral), which cannot be readily optimized for the delivery and dosing of
a significant portion of biologically derived drug substances.
Highlights
- Analyzes and evaluates nasal sprays for systemic drug deliveryand
development-stage candidates and assesses risks and market potential
- Analyzes nasal spray product strategies, technologies and patch
development issues
- Provides assessments of intranasal systemic drug products, key design
factors and strategic device factors
- Provides market data and forecasts to 2016
- Profiles market sector participants, their product development activities
and business strategies
Methodology
Research methodology is based on primary research in the form of in-depth
interviews with key market participants, technology developers, distributors,
industry experts, and market influencers, a list that includes regulatory
officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including
trade journal articles, technical literature, industry publications, company
data sheets and published information, and statistical data from government
agencies and trade associations.
Forecasts and projections of market demand and future market activity are
derived using standard modeling and statistical techniques.
About Greystone Associates
Greystone Associates is a medical technology consulting firm focused on the
areas of medical market strategy, product commercialization, venture
development, and market research. We assist medical and healthcare market
participants in achieving their business objectives through the creation of
detailed development strategies, product commercialization programs, and
comprehensive market and technology research and analysis.
Our market research publications are designed, researched and written to
provide timely and insightful information and data on focused market segments,
with the aim of providing market participants with the essential knowledge to
refine and execute their marketing plans and financial targets.
Table of Contents
Executive Summary
Systemic Nasal Delivery Market Dynamics
- The Trend toward Self-Administration
- Demographic Shifts
- Managed Care Initiatives
- Growth in Home Healthcare
- Technology Market Drivers
- Competitive Landscape
Nasal Delivery Design Factors
- Absorption
- Bioavailability
- Device Design Parameters
- Nasal Delivery Pharmacokinetics
- Nasal Device Characteristics
Market Factors
- Regional Regulations
- Clinical Trials
- Indications and Off-Label Prescribing
- Managed Care and Payor Initiatives
- Rx-to-OTC Switching
Product Assessments and Market Prospects
- Approved Drug Products
- Butorphanol
- Desmopressin
- FluMist
- Fortical
- Imitrex
- Instanyl
- Lazanda
- Miacalcin
- Migranal
- Nicotrol
- Synarel
- Zomig
- Development-Stage Products
- Apomorphine
- Cytokines
- Emitasol
- Exenatide
- Insulin
- Ketamine
- Leuprolide
- Morphine
- Parathyroid
- Peptides
- Triazolam
Nasal Delivery Indications and Markets
- Addiction
- Anti-Emetics
- Autism
- Diabetes
- Endocrine Therapy
- Immune Therapeutics
- Migraine
- Metabolic Disorders
- Osteoporosis
- Pain Management
- Parkinson's Disease
- Reproductive Medicine
- Sleep Disorders
- Urology
Market Forecasts
- Forecast Methodology
- Forecasts by Region
- Market Share Data
Company Profiles
